2017
DOI: 10.4103/ijp.ijp_183_17
|View full text |Cite
|
Sign up to set email alerts
|

Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder

Abstract: AIMS AND OBJECTIVES:The primary aim was an evaluation of the pattern of gross congenital malformations in a rat model of autism spectrum disorder (ASD) and the secondary aim was characterization of the most common gross malformation observed.MATERIALS AND METHODS:In females, the late pro-oestrous phase was identified by vaginal smear cytology, and then, they were allowed to mate at 1:3 ratio (male: female). Pregnancy was confirmed by the presence of sperm plug in the vagina and presence of sperm in the vaginal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 53 publications
1
2
0
Order By: Relevance
“…On the other hand, analogous to the previous study, Ruhela et al (2017) observed anatomical malformations in prenatally VPA-administered Wistar rats. Compared to the above studies, our findings reported similar observations that female rats cannibalize malformed pups compared to healthy pups (Figure 1, Table 3).…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…On the other hand, analogous to the previous study, Ruhela et al (2017) observed anatomical malformations in prenatally VPA-administered Wistar rats. Compared to the above studies, our findings reported similar observations that female rats cannibalize malformed pups compared to healthy pups (Figure 1, Table 3).…”
Section: Discussionsupporting
confidence: 89%
“…The volume was prepared as 250 mg/mL. Similarly, control dams (n=10) received an equal volume of saline at GD 12.5 days (Ruhela et al, 2017). Administration and route of VPA (600 mg/kg, IP) was chosen as it has been shown to cause higher significance of ASD symptoms than other doses (300, 400, 500 mg/kg) (Chaliha et al, 2020).…”
Section: Vpa Administrationmentioning
confidence: 99%
See 1 more Smart Citation